
View larger version (79K):
[in a new window]
|
Fig. 2. Microfilaments, not microtubules, are required for EF-mediated migration. (A) Inhibiting dynamic microfilaments blocks motility. Micrographs document positions of numbered cells initially (0 hours; a,c) and after 2 hours (b,d), EF exposure (6 V cm-1), with (a,b) or without (c,d) cytochalasin B (2 µM, 1.5 hours pretreatment). Cytochalasin completely abrogated motility, as quantified in (C) [see supplementary movies of drug-treated Cyto_6V_2hr and control cells Sparse_6V_2hr (http://jcs.biologists.com/supplemental/)]. The array of actin-containing structures visualized with anti-actin immunofluorescence (e,g) and rhodamine phalloidin (f,h) is shown with (e,f) and without (g,h) cytochalasin B. Notice that, although abundant microfilament structures remain in drug-treated cells (e,f), brightly labeled actin arc-like assemblies at cathode-facing edges are present only in control cells (g,h); compare thick white arrows in (e,g). EF direction shown by (+) and (-), and migration direction by thin arrows. Scale bars, 20 µm (phase-contrast) and 10 µm (immunofluorescence). (B) Inhibiting MTs slows EF-mediated motility. Micrographs show positions of numbered cells initially (0 hours; a,c) and after 2 hours (b,d), EF exposure (6 V cm-1), with (a,b) or without (c,d) Colcemid pretreatment (15 µM, 2 hours). Breakdown of all cellular MTs (see anti-tubulin immunofluorescence, e,f) slows but does not stop motility [quantified in Fig. 2C; compare supplementary movies of drug-treated (Colcemid_6V_2hr) and control (Sparse_6V_2hr) cells (http://jcs.biologists.com/supplemental/)]. Notice that the alignment perpendicular to motility direction is blocked by Colcemid (compare a,c, to b,d). EF direction shown by (+) and (-), and migration direction by thin arrows. Scale bars, 20 µm (phase-contrast) and 10 µm (immunofluorescence). (C) EF-mediated motility requires microfilaments, not MTs. Average migration speed and directional motility [speedxsin( ); Fig. 1A] in the EF (6 V cm-1; 2 hours) was quantified in cells treated to inhibit microfilaments (Cytochalasin B) or MTs (Colcemid), and compared with untreated cells (Control). Unlike cells lacking dynamic microfilaments, which showed no movement, cells lacking MTs displayed EF-mediated directional motility that was merely decreased in speed relative to controls.
|